Business
Currency:EUR
2024/FY
Stock NameRevenueRatio
Biopharmaceutical and Diagnostic Solutions937.78M84.94%
Engineering357.64M32.39%
Adjustments, eliminations and unallocated items-191.38M-17.33%
Region
Currency:EUR
2024/FY
Stock NameRevenueRatio
EMEA667.83M60.49%
South America308.95M27.98%
APAC96.24M8.72%
North America31.02M2.81%